Pia Thalén

Thiazolidinediones Increase Plasma-Adipose Tissue FFA Exchange Capacity and Enhance Insulin-Mediated Control of Systemic FFA Availability

Nicholas D. Oakes, Pia Thalén, Severina M. Jacinto et al. · Diabetes · 2001 · 170 citations · Full text

Metabolic Remodeling, Fatty Liver Disease, Insulin Signaling +20

Involvement of the metabolic sensor GPR81 in cardiovascular control

Kristina Wallenius, Pia Thalén, Jan‐Arne Björkman et al. · JCI Insight · 2017 · 57 citations · Full text

Hypertension, Metabolic Remodeling, Gpr81 Agonism +19

Cardiac metabolism in mice: tracer method developments and in vivo application revealing profound metabolic inflexibility in diabetes

Nicholas D. Oakes, Pia Thalén, Ellen Aasum et al. · American Journal of Physiology-Endocrinology and Metabolism · 2005 · 48 citations

Tesaglitazar, a dual PPARα/γ agonist, ameliorates glucose and lipid intolerance in obese Zucker rats

Nicholas D. Oakes, Pia Thalén, Therese Hultstrand et al. · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · 2005 · 36 citations

Metabolic Disorder, Glucose Tolerance, Insulin Signaling +18

PPARγ agonist induced cardiac enlargement is associated with reduced fatty acid and increased glucose utilization in myocardium of Wistar rats

Amanda J. Edgley, Pia Thalén, Björn Dahllöf et al. · European Journal of Pharmacology · 2006 · 25 citations

Obesity, Metabolic Syndrome, Cardiomyopathy +10